NDC11 75834021700
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 75834-0217-0 | 75834-0217 |
| 75834-0217-00 | 75834-0217 |
| 75834-217-00 | 75834-217 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VENLAFAXINE HYDROCHLORIDE | VENLAFAXINE HYDROCHLORIDE | Nivagen Pharmaceuticals, Inc. | 45cb4c19-fbf4-4ff5-af6f-b25a31ebc1e1 | 2021-01-14 | Boxed warning, Warnings, Adverse reactions | 75834-217-00 75834-217 75834021700 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.